I have a position in GALT. Phase 2 trial of be
Post# of 145214
Phase 2 trial of belapectin did not meet the endpoint in fibrosis, however it was shown to stop the development of esophageal varices. It was a surprise result but highly beneficial to any patient with late stage NASH (the mechanism of action is unknown at this point).
In pre-clinical trials for melanoma it was quite successful in tumor shrinkage.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)